LAUREN BAPST: Open Payments
NPI 1588430714 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,514 in 101 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $3,091 · 2025 $2,514
Food & beverage: $2,514
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $304 |
| Merck Sharp & Dohme LLC | 9 | $280 |
| PFIZER INC. | 10 | $239 |
| Novartis Pharmaceuticals Corporation | 9 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $176 |
| Amgen Inc. | 10 | $173 |
| E.R. Squibb & Sons, L.L.C. | 8 | $173 |
| Impulse Dynamics (USA) Inc. | 4 | $169 |
| Esperion Therapeutics, Inc. | 9 | $150 |
| BIOTRONIK INC. | 1 | $124 |
Products named: ELIQUIS, JARDIANCE, REPATHA, Optimizer, VERQUVO, LEQVIO, NEXLETOL, FARXIGA.
Industry payments across SC — which companies pay providers there.
